featured
Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes and PAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME
Circulation 2017 Nov 13;[EPub Ahead of Print], S Verma, CD Mazer, M Al-Omran, SE Inzucchi, D Fitchett, U Hehnke, JT George, B ZinmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.